Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab [RoActemra/Actemra];   Drug: Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)
Sponsor:   Hoffmann-La Roche
Not yet recruiting - verified July 2011